Pakistan’s HIV Crisis Deepens as 20,000 Patients Vanish from Treatment Networks

ISLAMABAD — Pakistan’s national HIV response has hit a critical breaking point. In a briefing that has sent shockwaves through the regional public health community, health officials informed a National Assembly parliamentary committee this week that nearly 20,000 individuals who began life-saving antiretroviral therapy (ART) have disappeared from the healthcare system.

The report, presented between May 4 and 5, 2026, highlights a catastrophic “retention gap” in what is already one of the fastest-growing HIV epidemics in the Eastern Mediterranean region. While the country has made strides in opening new clinics, the data suggests that getting patients into the waiting room is only half the battle; keeping them alive and on medication remains a daunting challenge.

The Scale of the “Missing”

According to data shared with the parliamentary committee, the disconnect between those who need help and those receiving it is widening. Pakistan currently has an estimated 369,000 people living with HIV (PLHIV). However, only 84,000 are officially registered with the government.

The most alarming figure involves the “missing” 20,000. These are individuals who were successfully diagnosed and started on ART but have since lost contact with health centers.

Key Epidemiological Trends (2010–2024)

Data from the World Health Organization (WHO) and UNAIDS illustrate a decade of escalating risk:

• New Infection Surge: New infections rose by 200% over 15 years, jumping from 16,000 in 2010 to 48,000 in 2024.

• Low Awareness: Only 21% of people living with HIV in Pakistan know their status.

• Treatment Deficit: Only 16% of the total estimated HIV population is currently on treatment.

• Viral Suppression: A mere 7% of patients have reached “viral suppression”—the point where the virus is undetectable and cannot be transmitted to others.

Why “Lost to Follow-Up” is a Public Health Emergency

Antiretroviral therapy is not a temporary fix; it is a lifelong commitment. When a patient stops taking ART, the virus—which had been suppressed—rapidly rebounds.

“The ‘missing patients’ problem is not just a clerical error or a paperwork issue,” says a public health analyst familiar with the region’s challenges. “It represents a breakdown in the human connection between the patient and the provider. When a person drops out of care, their health deteriorates, and the risk of community transmission increases significantly.”

A 2022 qualitative study published in Frontiers in Pharmacology identified several “structural and social walls” that prevent Pakistanis from staying on treatment:

1. Stigma and Discrimination: Fear of being ostracized by family or fired from work.

2. Economic Constraints: Even if medicine is free, the cost of transport to distant clinics is often prohibitive.

3. Religious Concerns: Misunderstandings regarding the compatibility of treatment with religious practices.

4. Systemic Gaps: Weak social support and inconsistent drug supplies.

Expert Perspectives: A “Stark Reminder”

Dr. Luo Dapeng, the WHO Representative in Pakistan, characterized the recent outbreaks—particularly those affecting children—as a “stark reminder” that current efforts are insufficient.

The crisis is increasingly shifting toward younger populations. Cases among children (ages 0–14) rose from 530 in 2010 to 1,800 in 2023. These infections are largely attributed to unsafe medical practices, such as the reuse of syringes and poorly screened blood transfusions.

Dr. Ayesha Majeed Isani, Pakistan’s Health Director General, emphasized that the solution must extend beyond the clinic walls. “The response must involve communities, regulators, and clinicians to end unsafe injection practices,” she stated, noting that localized “hot spots” in South Punjab and Taunsa have exposed severe weaknesses in infection control.

The Stigma Factor

The numbers are reinforced by a 2024 UNDP-supported Stigma Index study. Of 1,500 people surveyed:

• 17% reported facing family discrimination after disclosing their status.

• 20% claimed they were tested for HIV without their knowledge or consent.

  Such violations of privacy and dignity drive patients into the shadows, making them hesitant to return for follow-up appointments.

Understanding the Limitations

While the figure of 20,000 “missing” patients is staggering, health officials urge a nuanced interpretation. Being “lost to follow-up” does not definitively mean all 20,000 individuals have ceased treatment.

Some may have:

• Transferred to private clinics not linked to the national registry.

• Relocated to different provinces or moved abroad.

• Passed away without the health center being notified.

However, without a robust tracking system or a patient-level audit, the government must assume the worst-case scenario: that thousands of individuals are currently without the medication they need to survive.

What This Means for the Public

For the general audience and healthcare providers alike, the message is clear: HIV is a manageable chronic condition, but only through consistency.

• For Patients: Continuity of care is life. Stopping ART can lead to drug-resistant strains of HIV, making future treatment much more difficult.

• For the Public: Testing is the only way to know your status. In a country where only 1 in 5 people with HIV are aware they have it, routine screening—especially for those who have received medical injections or blood transfusions in unregulated settings—is vital.

• For the Healthcare System: There is an urgent need to shift from “passive” care (waiting for patients to show up) to “active” care (community-based support and digital tracking to ensure no one falls through the cracks).

As Pakistan grapples with these disappearing thousands, the goal of ending AIDS as a public health threat by 2030 remains a distant, though necessary, ambition.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• Dawn, “Nearly 20,000 patients ‘missing’ after initiating treatment at HIV centres, NA committee told,” May 4, 2026.